This case was last updated from PACER on 08/05/2019 at 08:06:18 (UTC).

Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.

Case Summary

On 06/06/2019 Novartis Pharmaceuticals Corporation filed an Intellectual Property - Patent lawsuit against Mylan Pharmaceuticals Inc. This case was filed in U.S. District Courts, West Virginia Northern District. The Judge overseeing this case is Irene M. Keeley. The case status is Pending - Other Pending.

Case Details Parties Documents Dockets

 

Case Details

  • Case Number:

    1:19-CV-00120

  • Filing Date:

    06/06/2019

  • Case Status:

    Pending - Other Pending

  • Case Type:

    Intellectual Property - Patent

  • Court:

    U.S. District Courts

  • Courthouse:

    West Virginia Northern District

Judge Details

Presiding Judge

Irene M. Keeley

 

Party Details

Plaintiffs

Novartis Pharmaceuticals Corporation

Novartis AG

Defendant

Mylan Pharmaceuticals Inc.

Attorney/Law Firm Details

Plaintiff Attorneys

James F. Companion

Attorney at Schrader Companion Duff & Law, PLLC

401 Main Street

Wheeling, WV 26003

Nicholas N. Kallas

Attorney at Venable, LLP

1290 Avenue Of The Americas

New York, NY 10104

 

Court Documents

#9

(#9) ORDER granting #7 Motion for Leave to Appear Pro Hac Vice for Attorney Nicholas N. Kallas. Signed by Senior Judge Irene M. Keeley on 6/11/2019. (jmm) (Entered: 06/11/2019)

#8

RESTRICTED

7 #1

Text of Proposed Order

#7

(#7) MOTION for Leave to Appear Pro Hac Vice of Nicholas N. Kallas by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: #1 Text of Proposed Order)(Companion, James) (Entered: 06/11/2019)

#6

(#6) VERIFICATION OF ATTORNEY ADMISSION.(sent via email) (jmm) (Entered: 06/06/2019)

#5

(#5) Corporate Disclosure Statement by Novartis AG. (jmm) (Entered: 06/06/2019)

#4

(#4) Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (jmm) (Entered: 06/06/2019)

#3

(#3) REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jmm) (Entered: 06/06/2019)

#2

RESTRICTED

1 #5

Civil Cover Sheet

1 #4

Suppleement Information for Patenet Cases Involving An Abbreviatd New Drug Appl

1 #3

Exhibit Patent No. US 8,436,010 B2

1 #2

Exhibit B Patent Number US 8,778,962 B2

1 #1

Exhibit A Patent Number 5,665,772

#1

(#1) COMPLAINT against Mylan Pharmaceuticals Inc., filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: #1 Exhibit A Patent Number 5,665,772, #2 Exhibit B Patent Number US 8,778,962 B2, #3 Exhibit C Patent No. US 8,436,010 B2, #4 Suppleement Information for Patenet Cases Involving An Abbreviatd New Drug Appliation (ANDA), #5 Civil Cover Sheet)(jmm) (Entered: 06/06/2019)

5 More Documents Available

 

Docket Entries

  • 06/11/2019
  • View Court Documents
  • (#9) ORDER granting #7 Motion for Leave to Appear Pro Hac Vice for Attorney Nicholas N. Kallas. Signed by Senior Judge Irene M. Keeley on 6/11/2019. (jmm) (Entered: 06/11/2019)

    Read MoreRead Less
  • 06/11/2019
  • View Court Documents
  • (#8) Pro Hac Vice Filing fee as to Nicholas N. Kallas: PAID $ 200.00, receipt number WVNC002628. (wrr) (Entered: 06/11/2019)

    Read MoreRead Less
  • 06/11/2019
  • View Court Documents
  • (#7) MOTION for Leave to Appear Pro Hac Vice of Nicholas N. Kallas by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: #1 Text of Proposed Order)(Companion, James) (Entered: 06/11/2019)

    Read MoreRead Less
  • 06/06/2019
  • View Court Documents
  • (#6) VERIFICATION OF ATTORNEY ADMISSION.(sent via email) (jmm) (Entered: 06/06/2019)

    Read MoreRead Less
  • 06/06/2019
  • View Court Documents
  • (#5) Corporate Disclosure Statement by Novartis AG. (jmm) (Entered: 06/06/2019)

    Read MoreRead Less
  • 06/06/2019
  • View Court Documents
  • (#4) Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (jmm) (Entered: 06/06/2019)

    Read MoreRead Less
  • 06/06/2019
  • View Court Documents
  • (#3) REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jmm) (Entered: 06/06/2019)

    Read MoreRead Less
  • 06/06/2019
  • View Court Documents
  • (#2) Filing fee: $ 400.00, receipt number WVNW002198. (jmm) (Entered: 06/06/2019)

    Read MoreRead Less
  • 06/06/2019
  • View Court Documents
  • (#1) COMPLAINT against Mylan Pharmaceuticals Inc., filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: #1 Exhibit A Patent Number 5,665,772, #2 Exhibit B Patent Number US 8,778,962 B2, #3 Exhibit C Patent No. US 8,436,010 B2, #4 Suppleement Information for Patenet Cases Involving An Abbreviatd New Drug Appliation (ANDA), #5 Civil Cover Sheet)(jmm) (Entered: 06/06/2019)

    Read MoreRead Less

Please submit a removal request if you do not want this court record to appear in search engine results.